Why Is Apellis Pharmaceuticals (APLS) Up 18.4% Since Last Earnings Report? Dec. 5, 2024 at 11:30 a.m. ET on Zacks.com Why Bio-Techne Corp (TECH) Is Set to Outperform the Market: Insights into Financial Growth and ... Dec. 2, 2024 at 10:01 a.m. ET on GuruFocus.com Sho...
Nektar (NKTR) — NKTR Inks Two Partners, Merck & SFJ Pharmaceuticals (Abingworth & Blackstone Life Sciences) for BEMPEG Combo Registration Trials Posted: February 17, 2021 BIOINVEST BREAKING NEWS – This morning NKTR announced that it has signed two deals to advance BEMPEG combos – one with ...
Hengrui Pharmaceuticals, Sino Biopharmaceutical and Shanghai Pharma were the top three in the list. About the “2022 China Pharmaceutical Brands List” The “2022 China Pharmaceutical Brands List” has rigourously screened the shortlisted brands based on the sales amount and growth rate of products...
InventisBio Co Ltd 688382:SHH Actions Health CarePharmaceuticals and Biotechnology Price (CNY)13.30 Today's Change 0.22 / 1.68% Shares traded12.49m 1 Year change-9.71% Beta-- Data delayed at least 15 minutes, as of Dec 31 2024. Find More Stocks...
pharmaceuticals | A&D Weighing | a.g scientific | Aalto | Aalto Scientific | aaltoscientific | aat bioquest | aat bioquest inc | AB Biolabs | ab peptides | ab sciex | abbexa | abbiotec | abbott laboratories | abcore-inc | abcysonline | abd | abd serotec | ab-direct | abdserotec | ...
诺和诺德(NVO.US)周一表示,已同意以最高10.3亿欧元(11.1亿美元)的价格收购Cardior Pharmaceuticals,以加强其心血管药物管线。诺和诺德表示,该交易包括Cardior的先导化合物CDR132L,目前正处于治疗心力衰竭的2期临床开发阶段。该公司表示,交易价格包括预付款和如果实现某些开发和商业里程碑的额外付款,并补充道,它将从财务...
and drug launch & marketing. Ms. Christina J. Ansted has worked in increasing leadership roles with Alexion Pharmaceuticals, Agilis Therapeutics, and PTC Therapeutics. Dr. Hui Huang held various leadership roles at Millennium, ...
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company...
Cosmos Health Inc. announced the successful acquisition of the distribution network owned by Pharmatrade S.A., an established pharmaceutical wholesale company operating in Greece.
IPO后,LAV Fund VI, L.P.持股为6.4%,Octagon Capital Advisors LP持股为5.7%,OrbiMed持股为8.4%,Shanghai Allist Pharmaceuticals持股为4.2%,Sofinnova Venture Partners XI持股为4.1%; 高瓴持股为12.8%,Sirona Capital Partners Ltd.持股4.2%,Zhengbin (Bing) Yao, Ph.D.持股为2.7%,Robin LaChapelle持股为1.6...